Reimbursement complexity is addiction treatment’s biggest unsolved problem. About 1 in 6 Americans met the criteria for a substance use disorder in 2024, according to the Substance Abuse and Mental Health Services Administration. National spending on substance use disorder (SUD) and mental health treatment has grown from roughly $41 billion in 2000 to nearly $140 billion by 2021. And yet only about 1 in 5 of those who needed treatment actually received it.
We fixed opioid coverage but not the system behind it
Why This Matters
While recent efforts have improved insurance coverage for opioid treatment, the underlying reimbursement system remains complex and inefficient, hindering access to care. Addressing these systemic issues is crucial for expanding effective treatment and reducing the burden of substance use disorders on both individuals and the healthcare system. Simplifying reimbursement processes could lead to better resource allocation and improved patient outcomes in the future.
Key Takeaways
- Reimbursement complexity is a major barrier to effective addiction treatment.
- Only 20% of those needing treatment currently receive it.
- Systemic reforms are needed to improve access and efficiency in SUD care.
Get alerts for these topics